Related Experiment Video
Updated: Apr 18, 2026
Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation
Keigo Suetani1, Chiaki Okuse1, Kazunari Nakahara1
1Keigo Suetani, Chiaki Okuse, Kazunari Nakahara, Yosuke Michikawa, Yohei Noguchi, Midori Suzuki, Ryo Morita, Nozomi Sato, Masaki Kato, Fumio Itoh, Department of Gastroenterology and Hepatology, St. Marianna University, School of Medicine, Kawasaki 216-8511, Japan.
Insights
Recombinant thrombomodulin (rTM) therapy improved disseminated intravascular coagulation (DIC) resolution rates in patients with acute cholangitis (AC)-induced DIC. While rTM showed benefits, biliary drainage for AC remains essential for managing persistent DIC.
Area of Science:
- Critical Care Medicine
- Hematology
- Gastroenterology
Background:
- Acute cholangitis (AC) can lead to disseminated intravascular coagulation (DIC), a life-threatening condition.
- Effective management of AC-induced DIC is crucial for patient outcomes.
- Recombinant thrombomodulin (rTM) is a potential therapeutic agent for DIC.
Purpose of the Study:
- To evaluate the efficacy of rTM as an add-on therapy for AC-induced DIC.
- To compare outcomes in patients treated with and without rTM.
- To identify factors associated with persistent DIC in this patient population.
Main Methods:
- A retrospective study comparing 30 patients treated with rTM (rTM group) and 36 patients treated without rTM (control group) for AC-induced DIC.
- Diagnoses based on 2013 Tokyo Guidelines for AC and Japanese Association for Acute Medicine criteria for DIC.
- Comparison of patient characteristics, DIC resolution rates, DIC and SIRS scores, hematological values, and mortality. Multivariate logistic regression was used to identify factors for persistent DIC.
Main Results:
- DIC resolution by day 9 was significantly higher in the rTM group (83.3%) compared to the control group (52.8%) (P < 0.01).
- Mean DIC scores on day 7 and SIRS scores on day 3 were significantly lower in the rTM group.
- Absence of biliary drainage was the only factor significantly associated with persistent DIC (OR = 12).
Conclusions:
- rTM therapy demonstrates add-on benefits in improving DIC resolution rates for AC-induced DIC.
- Biliary drainage for AC is a critical intervention for managing persistent DIC.
- While not statistically significant, malignancy and non-use of rTM showed a tendency towards association with persistent DIC.
Aim:
To evaluate the need for thrombomodulin (rTM) therapy for disseminated intravascular coagulation (DIC) in patients with acute cholangitis (AC)-induced DIC.
Methods:
Sixty-six patients who were diagnosed with AC-induced DIC and who were treated at our hospital were enrolled in this study. The diagnoses of AC and DIC were made based on the 2013 Tokyo Guidelines and the DIC diagnostic criteria as defined by the Japanese Association for Acute Medicine, respectively. Thirty consecutive patients who were treated with rTM between April 2010 and September 2013 (rTM group) were compared to 36 patients who were treated without rTM (before the introduction of rTM therapy at our hospital) between January 2005 and January 2010 (control group). The two groups were compared in terms of patient characteristics at the time of DIC diagnosis (including age, sex, primary disease, severity of cholangitis, DIC score, biliary drainage, and anti-DIC drugs), the DIC resolution rate, DIC score, the systemic inflammatory response syndrome (SIRS) score, hematological values, and outcomes. Using logistic regression analysis based on multivariate analyses, we also examined factors that contributed to persistent DIC.
Results:
There were no differences between the rTM group and the control group in terms of the patients' backgrounds other than administration. DIC resolution rates on day 9 were higher in the rTM group than in the control group (83.3% vs 52.8%, P < 0.01). The mean DIC scores on day 7 were lower in the rTM group than in the control group (2.1 ± 2.1 vs 3.5 ± 2.3, P = 0.02). The mean SIRS scores on day 3 were significantly lower in the rTM group than in the control group (1.1 ± 1.1 vs 1.8 ± 1.1, P = 0.03). Mortality on day 28 was 13.3% in the rTM group and 27.8% in the control group; these rates were not significantly different (P = 0.26). Multivariate analysis identified only the absence of biliary drainage as significantly associated with persistent DIC (P < 0.01, OR = 12, 95%CI: 2.3-60). Although the difference did not reach statistical significance, primary diseases (malignancies) (P = 0.055, OR = 3.9, 95%CI: 0.97-16) and the non-use of rTM had a tendency to be associated with persistent DIC (P = 0.08, OR = 4.3, 95%CI: 0.84-22).
Conclusion:
The add-on effects of rTM are anticipated in the treatment of AC-induced DIC, although biliary drainage for AC remains crucial.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care